Trial Profile
Trial of pyrazoloacridine in children with refractory solid tumors
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 12 Dec 2005
Price :
$35
*
At a glance
- Drugs PD 115934 (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 12 Dec 2005 New trial record.